Coronary interventions
Second-generation drug-eluting absorbable metal scaffold target-lesion revascularization: an optical coherence tomography case series study and literature review September 3, 2019 | 10.4244/EIJ-D-19-00421
Showing 1-20 of 91 articles
Coronary interventions
Randomised evaluation of a novel biodegradable polymer-based sirolimus-eluting stent in ST-segment elevation myocardial infarction: the MASTER study April 5, 2019 | 10.4244/EIJ-D-17-01087
Coronary interventions
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: 3-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial February 26, 2019 | 10.4244/EIJ-D-18-01000
STEMI
SYNTAX score in relation to intravascular ultrasound and near-infrared spectroscopy for the assessment of atherosclerotic burden in patients with coronary artery disease January 18, 2019 | 10.4244/EIJ-D-17-00827
The European Collaborative Project on Inflammation and Vascular Wall Remodeling in Atherosclerosis - Intravascular Ultrasound (ATHEROREMO-IVUS) study
June 20, 2018 | 10.4244/EIJ-D-17-00180
The effect of coronary bifurcation and haemodynamics in prediction of atherosclerotic plaque development: a serial computed tomographic coronary angiographic study
October 11, 2017 | 10.4244/EIJ-D-16-00929
Coronary interventions
Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III July 20, 2017 | 10.4244/EIJ-D-17-00254
Coronary interventions
Sex differences in plaque characteristics by intravascular imaging in patients with coronary artery disease June 20, 2017 | 10.4244/EIJ-D-16-00361
Coronary interventions
Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial November 20, 2016 | 10.4244/EIJY15M11_07
Coronary interventions
Chipping of calcified plaques by orbital atherectomy systems, but holding approval tight: is the FDA moving faster than the European CE agency? A North American perspective October 20, 2016 | 10.4244/EIJV12I9A178
Coronary interventions
Clinical outcomes of “complete, partially complete, and incomplete” revascularisation at five-year follow-up after percutaneous intervention of unprotected left main coronary artery disease with drug-eluting stents October 10, 2016 | 10.4244/EIJY15M12_06
Coronary interventions
Variability in the measurement of minimum fibrous cap thickness and reproducibility of fibroatheroma classification by optical coherence tomography using manual versus semi-automatic assessment October 10, 2016 | 10.4244/EIJV12I8A162
Coronary interventions
Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries August 20, 2016
Coronary interventions
Evaluation of vascular healing of polymer-free sirolimus-eluting stents in native coronary artery stenosis: a serial follow-up at three and six months with optical coherence tomography imaging August 5, 2016 | 10.4244/EIJV12I5A97
Coronary interventions
Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study July 20, 2016 | 10.4244/EIJY15M08_03
Coronary interventions
Comparison of clinical outcomes between bioresorbable vascular stents versus conventional drug-eluting and metallic stents: a systematic review and meta-analysis June 10, 2016 | 10.4244/EIJY16M06_02
